Michael Aaron Kelly

Insider Reports History

Location
C/O Hookipa Pharma Inc., 430 East 29 Th St., New York, NY
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Aaron Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AMICUS THERAPEUTICS, INC. Director Common Stock 72.5K $450K $6.21 Jun 5, 2025 Direct
DMC Global Inc. Director Common Stock 48.7K $410K $8.42 May 14, 2025 Direct
NEOGENOMICS INC Director Common Stock 44K $339K $7.70 Jun 1, 2025 Direct
NEOGENOMICS INC Director Restricted Stock Unit 12.3K $193K $15.74 Jun 1, 2024 Direct
NEOGENOMICS INC Director Restricted Stock Unit 23.1K $126K $10.27 Jun 1, 2025 Direct
NEOGENOMICS INC Director Stock Option (Right to Buy) 16.1K $89.1K $10.27 Jun 1, 2025 Direct
HOOKIPA Pharma Inc. Director Stock Option (Right to Buy) 20K $60K $3.00 Jun 30, 2022 Direct
NEOGENOMICS INC Director Common Stock 5K $38.5K $7.70 Jun 1, 2025 M Kelly & B Kelly TTEE Michael and Bonnie Kelly Revocable Trust DTD 05/02/2016
Aprea Therapeutics, Inc. Director Common Stock 4.61K $17K $3.68 Jun 30, 2021 Direct
AMICUS THERAPEUTICS, INC. Director Stock Options (right to buy) 74.9K Jun 5, 2025 Direct
Prime Medicine, Inc. Director Stock Option (right to buy) 45K Aug 1, 2025 Direct
AMICUS THERAPEUTICS, INC. Director Stock Options (right to buy) 42.5K Jun 6, 2024 Direct
Aprea Therapeutics, Inc. Director Stock Option (Right to Buy) 22.8K Jun 30, 2021 Direct

Insider Reports Filed by Michael Aaron Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRME Prime Medicine, Inc. Aug 1, 2025 8 $0 4 Aug 5, 2025 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 5, 2025 2 $0 4 Jun 6, 2025 Director
PRME Prime Medicine, Inc. Jun 4, 2025 1 $0 4 Jun 5, 2025 Director
NEO NEOGENOMICS INC Jun 1, 2025 4 $0 4 Jun 3, 2025 Director
NEO NEOGENOMICS INC May 27, 2025 1 $38K 4 May 28, 2025 Director
BOOM DMC Global Inc. May 14, 2025 1 $0 4 May 15, 2025 Director
BOOM DMC Global Inc. Feb 26, 2025 1 $0 4 Feb 27, 2025 Director
NEO NEOGENOMICS INC Aug 10, 2024 2 $0 4 Aug 13, 2024 Director
PRME Prime Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 6, 2024 2 $0 4 Jun 7, 2024 Director
NEO NEOGENOMICS INC Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
BOOM DMC Global Inc. May 15, 2024 1 $0 4 May 15, 2024 Director
NEO NEOGENOMICS INC Aug 10, 2023 2 $0 4 Aug 14, 2023 Director
PRME Prime Medicine, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
BOOM DMC Global Inc. May 10, 2023 1 $0 4 May 10, 2023 Director
PRME Prime Medicine, Inc. Oct 19, 2022 1 $0 4 Oct 21, 2022 Director
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 Director
HOOK HOOKIPA Pharma Inc. Jun 30, 2022 1 $0 4 Jul 1, 2022 Director
NEO NEOGENOMICS INC Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 9, 2022 2 $0 4 Jun 10, 2022 Director
BOOM DMC Global Inc. May 11, 2022 1 $0 4 May 12, 2022 Director
APRE Aprea Therapeutics, Inc. Jun 30, 2021 2 $0 4 Jul 1, 2021 Director
FOLD AMICUS THERAPEUTICS, INC. Jun 10, 2021 2 $0 4 Jun 14, 2021 Director
NEO NEOGENOMICS INC Jun 2, 2021 2 $0 4 Jun 4, 2021 Director
HOOK HOOKIPA Pharma Inc. Jun 1, 2021 1 $0 4 Jun 4, 2021 Director
BOOM DMC Global Inc. May 12, 2021 1 $0 4 May 14, 2021 Director